{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:33:50Z","timestamp":1787960030326,"version":"build-2784847793"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cardiotoxicity is one of the most common adverse events of the chemotherapy. Physical exercise was shown to be cardioprotective. We aim to estimate the efficacy and safety of exercise in cancer patients receiving cardiotoxic chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs), which were retrieved by systematically searching PubMed, Web of Science, SCOPUS, Cochrane, Clinical Trials.gov, and MedRxiv through July 17th, 2023. We used RevMan V. 5.4 to pool dichotomous data using risk ratio (RR) and continuous data using mean difference (MD), with a 95% confidence interval (CI). PROSPERO ID: CRD42023460902.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We included thirteen RCTs with a total of 952 patients. Exercise significantly increased VO<jats:sub>2<\/jats:sub> peak (MD: 1.95 with 95% CI [0.59, 3.32], <jats:italic>P<\/jats:italic>\u2009=\u20090.005). However, there was no significant effect regarding left ventricular ejection fraction, global longitudinal strain, cardiac output, stroke volume, left ventricular end-diastolic volume, left ventricular end-systolic volume, E\/A ratio, resting heart rate, peak heart rate, resting systolic blood pressure, and resting diastolic blood pressure. Also, there was no significant difference regarding any adverse events (AEs) (RR: 4.44 with 95% CI [0.47, 41.56], <jats:italic>P<\/jats:italic>\u2009=\u20090.19), AEs leading to withdrawal (RR: 2.87 with 95% CI [0.79, 10.43], <jats:italic>P<\/jats:italic>\u2009=\u20090.11), serious AEs (RR: 3.00 with 95% CI [0.14, 65.90], <jats:italic>P<\/jats:italic>\u2009=\u20090.49), or all-cause mortality (RR: 0.25 with 95% CI [0.03, 2.22], <jats:italic>P<\/jats:italic>\u2009=\u20090.21).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Exercise is associated with increased VO<jats:sub>2<\/jats:sub> peak in cancer patients receiving cardiotoxic chemotherapy. However, there was no significant difference between exercise and usual care regarding the echocardiographic and safety outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40959-024-00208-2","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T07:02:33Z","timestamp":1708671753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The efficacy and safety of exercise regimens to mitigate chemotherapy cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"10","author":[{"given":"Ahmed Mazen","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehya","family":"Khlidj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuelazm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Tanashat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam","family":"Shaikhkhalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Abdelazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"issue":"1","key":"208_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/djp440","volume":"102","author":"A Albini","year":"2010","unstructured":"Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102(1):14\u201325.","journal-title":"J Natl Cancer Inst"},{"issue":"36","key":"208_CR2","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines. Eur Heart J. 2016;37(36):2768\u2013801.","journal-title":"Eur Heart J"},{"issue":"5","key":"208_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/annonc\/mdf035","volume":"13","author":"N Frickhofen","year":"2002","unstructured":"Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrasch H, Sigmund M. Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol [Internet]. 2002;13(5):797\u2013801. https:\/\/doi.org\/10.1093\/annonc\/mdf035.","journal-title":"Ann Oncol [Internet]"},{"issue":"8","key":"208_CR4","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1634\/theoncologist.2012-0466","volume":"18","author":"DJ Lenihan","year":"2013","unstructured":"Lenihan DJ, Kowey PR. Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist. 2013;18(8):900\u20138.","journal-title":"Oncologist"},{"issue":"11","key":"208_CR5","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.117.024671","volume":"137","author":"JM Scott","year":"2018","unstructured":"Scott JM, Nilsen TS, Gupta D, Jones LW. Exercise therapy and cardiovascular toxicity in cancer. Circulation. 2018;137(11):1176\u201391.","journal-title":"Circulation"},{"issue":"12","key":"208_CR6","first-page":"643","volume":"31","author":"T Neuendorf","year":"2023","unstructured":"Neuendorf T, Haase R, Schroeder S, Schumann M, Nitzsche N. Effects of high-intensity interval training on functional performance and maximal oxygen uptake in comparison with moderate intensity continuous training in cancer patients: a systematic review and meta-analysis. Supp Care Cancer Off J Multinatl Assoc Supp Care Cancer. 2023;31(12):643.","journal-title":"Supp Care Cancer Off J Multinatl Assoc Supp Care Cancer"},{"issue":"Supplement","key":"208_CR7","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.4103\/0971-9784.192617","volume":"19","author":"S Chengode","year":"2016","unstructured":"Chengode S. Left ventricular global systolic function assessment by echocardiography. Ann Card Anaesth. 2016;19(Supplement):S26-34.","journal-title":"Ann Card Anaesth"},{"issue":"682","key":"208_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1098\/rspb.1924.0048","volume":"97","author":"AV Hill","year":"1997","unstructured":"Hill AV, Long CNH, Lupton H. Muscular exercise, lactic acid and the supply and utilisation of oxygen.\u2014 Parts VII\u2013VIII. Proc R Soc London Ser B Contain Pap a Biol Character. 1997;97(682):155\u201376. https:\/\/doi.org\/10.1098\/rspb.1924.0048.","journal-title":"Proc R Soc London Ser B Contain Pap a Biol Character."},{"issue":"9","key":"208_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/eurjpc\/zwad063","volume":"30","author":"P Antunes","year":"2023","unstructured":"Antunes P, Joaquim A, Sampaio F, Nunes C, Ascens\u00e3o A, Vilela E, et al. Effects of exercise training on cardiac toxicity markers in women with breast cancer undergoing chemotherapy with anthracyclines: a randomized controlled trial. Eur J Prev Cardiol. 2023;30(9):844\u201355.","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"208_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCULATIONAHA.122.062814","volume":"147","author":"SJ Foulkes","year":"2023","unstructured":"Foulkes SJ, Howden EJ, Haykowsky MJ, Antill Y, Salim A, Nightingale SS, et al. Exercise for the prevention of anthracycline-induced functional disability and cardiac dysfunction: the BREXIT study. Circulation. 2023;147(7):532\u201345.","journal-title":"Circulation"},{"issue":"12","key":"208_CR11","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1002\/cncr.31368","volume":"124","author":"JM Scott","year":"2018","unstructured":"Scott JM, Iyengar NM, Nilsen TS, Michalski M, Thomas SM, Herndon J 2nd, et al. Feasibility, safety, and efficacy of aerobic training in pretreated patients with metastatic breast cancer: a randomized controlled trial. Cancer. 2018;124(12):2552\u201360.","journal-title":"Cancer"},{"issue":"5","key":"208_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrclinonc.2012.27","volume":"9","author":"SG Lakoski","year":"2012","unstructured":"Lakoski SG, Eves ND, Douglas PS, Jones LW. Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol. 2012;9(5):288\u201396.","journal-title":"Nat Rev Clin Oncol"},{"key":"208_CR13","first-page":"372","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372.","journal-title":"BMJ"},{"key":"208_CR14","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al. Cochrane handbook for systematic reviews of interventions. Cochrane Handb Syst Rev Interv. 2019;1\u2013694.","DOI":"10.1002\/9781119536604"},{"key":"208_CR15","first-page":"1","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:1\u20138.","journal-title":"BMJ"},{"key":"#cr-split#-208_CR16.1","doi-asserted-by":"crossref","unstructured":"Guyatt GH OAKRVGFYYSHGWG. Guyatt2008. Bmj [Internet]. 2008;336(may):995-8. Available from: https:\/\/www.bmj.com\/content\/336\/7651\/995.long%0AGuyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Sch\u00fcnemann HJ","DOI":"10.1136\/bmj.39490.551019.BE"},{"key":"#cr-split#-208_CR16.2","doi-asserted-by":"crossref","unstructured":"GRADE Working Group. What is %22quality of evidence%22 and why is it important to clinicians? BMJ. 2008;336(7651):995-8. doi: 10.1136","DOI":"10.1136\/bmj.39490.551019.BE"},{"issue":"1","key":"208_CR17","first-page":"8","volume":"9","author":"GH Guyatt","year":"2009","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Chinese J Evid-Based Med. 2009;9(1):8\u201311.","journal-title":"Chinese J Evid-Based Med"},{"key":"208_CR18","unstructured":"RevMan | Cochrane Training [Internet]. [cited 2021 Aug 3]. Available from https:\/\/www.training.cochrane.org\/online-learning\/core-software-cochrane-reviews\/revman."},{"key":"208_CR19","unstructured":"Cochrane Handbook for Systematic Reviews Intervention. 2022;"},{"issue":"8","key":"208_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763\u20139. Available from:https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0895435607003691.","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"208_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17(1):1\u201318.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"208_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12885-019-5887-7","volume":"19","author":"K Lee","year":"2019","unstructured":"Lee K, Kang I, Mack WJ, Mortimer J, Sattler F, Salem G, et al. Feasibility of high intensity interval training in patients with breast cancer undergoing anthracycline chemotherapy: a randomized pilot trial. BMC Cancer. 2019;19(1):653.","journal-title":"BMC Cancer"},{"issue":"1","key":"208_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13102-022-00420-6","volume":"14","author":"KM Sturgeon","year":"2022","unstructured":"Sturgeon KM, Smith AM, Federici EH, Kodali N, Kessler R, Wyluda E, et al. Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients. BMC Sport Sci Med Rehabil. 2022;14(1):31.","journal-title":"BMC Sport Sci Med Rehabil"},{"issue":"3","key":"208_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/HCR.0000000000000388","volume":"39","author":"E Tsai","year":"2019","unstructured":"Tsai E, Mouhayar E, Lenihan D, Song J, Durand JB, Fadol A, et al. Feasibility and outcomes of an exercise intervention for chemotherapy-induced heart failure. J Cardiopulm Rehabil Prev. 2019;39(3):199\u2013203.","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"3","key":"208_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s10549-019-05204-0","volume":"175","author":"KA Bolam","year":"2019","unstructured":"Bolam KA, Mijwel S, Rundqvist H, Wengstr\u00f6m Y. Two-year follow-up of the OptiTrain randomised controlled exercise trial. Breast Cancer Res Treat. 2019;175(3):637\u201348.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"208_CR26","doi-asserted-by":"publisher","first-page":"101485","DOI":"10.1016\/j.rehab.2021.101485","volume":"65","author":"WP Chung","year":"2022","unstructured":"Chung WP, Yang HL, Hsu YT, Hung CH, Liu PY, Liu YW, et al. Real-time exercise reduces impaired cardiac function in breast cancer patients undergoing chemotherapy: a randomized controlled trial. Ann Phys Rehabil Med. 2022;65(2):101485.","journal-title":"Ann Phys Rehabil Med"},{"issue":"28","key":"208_CR27","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1200\/JCO.2006.08.2024","volume":"25","author":"KS Courneya","year":"2007","unstructured":"Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(28):4396\u2013404.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"208_CR28","doi-asserted-by":"crossref","unstructured":"Hojan K, Procyk D, Hory\u0144ska-K\u0119stowicz D, Leporowska E, Litwiniuk M. The preventive role of regular physical training in ventricular remodeling, serum cardiac markers, and exercise performance changes in breast cancer in women undergoing trastuzumab therapy-an REH-HER study. J Clin Med. 2020;9(5).","DOI":"10.3390\/jcm9051379"},{"issue":"1","key":"208_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/0284186X.2013.781673","volume":"53","author":"WE Hornsby","year":"2014","unstructured":"Hornsby WE, Douglas PS, West MJ, Kenjale AA, Lane AR, Schwitzer ER, et al. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial. Acta Oncol. 2014;53(1):65\u201374.","journal-title":"Acta Oncol"},{"key":"208_CR30","doi-asserted-by":"publisher","first-page":"1000846","DOI":"10.3389\/fcvm.2022.1000846","volume":"9","author":"Q Jacquinot","year":"2022","unstructured":"Jacquinot Q, Meneveau N, Falcoz A, Bouhaddi M, Roux P, Degano B, et al. Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab. Front Cardiovasc Med. 2022;9:1000846.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"208_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/HCR.0000000000000719","volume":"43","author":"DJ Kerrigan","year":"2023","unstructured":"Kerrigan DJ, Reddy M, Walker EM, Cook B, McCord J, Loutfi R, et al. Cardiac rehabilitation improves fitness in patients with subclinical markers of cardiotoxicity while receiving chemotherapy: a randomized controlled study. J Cardiopulm Rehabil Prev. 2023;43(2):129\u201334.","journal-title":"J Cardiopulm Rehabil Prev"},{"issue":"3","key":"208_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10549-017-4554-4","volume":"167","author":"AA Kirkham","year":"2018","unstructured":"Kirkham AA, Eves ND, Shave RE, Bland KA, Bovard J, Gelmon KA, et al. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Res Treat. 2018;167(3):719\u201329.","journal-title":"Breast Cancer Res Treat"},{"key":"208_CR33","doi-asserted-by":"publisher","first-page":"101937","DOI":"10.1016\/j.eclinm.2023.101937","volume":"59","author":"SN Thomsen","year":"2023","unstructured":"Thomsen SN, Lahart IM, Thomsen LM, Fridh MK, Larsen A, Mau-S\u00f8rensen M, et al. Harms of exercise training in patients with cancer undergoing systemic treatment: a systematic review and meta-analysis of published and unpublished controlled trials. eClinicalMedicine. 2023;59:101937. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101937.","journal-title":"eClinicalMedicine."},{"issue":"4","key":"208_CR34","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.3747\/co.24.3619","volume":"24","author":"R Segal","year":"2017","unstructured":"Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T. Exercise for people with cancer: a systematic review. Curr Oncol. 2017;24(4):e290-315.","journal-title":"Curr Oncol"},{"issue":"1","key":"208_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12966-020-01021-7","volume":"17","author":"B Singh","year":"2020","unstructured":"Singh B, Hayes SC, Spence RR, Steele ML, Millet GY, Gergele L. Exercise and colorectal cancer: a systematic review and meta-analysis of exercise safety, feasibility and effectiveness. Int J Behav Nutr Phys Act. 2020;17(1):122.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"208_CR36","unstructured":"Whipp B. The peak versus maximum oxygen uptake issue. CpxinternationalCom [Internet]. 2010;1\u201310. Available from: http:\/\/www.cpxinternational.com\/attachments\/028_BJW-Vo2PeakvsMaxfinal2.pdf"},{"issue":"1","key":"208_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1634\/theoncologist.2010-0197","volume":"16","author":"LW Jones","year":"2011","unstructured":"Jones LW, Liang Y, Pituskin EN, Battaglini CL, Scott JM, Hornsby WE, et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist. 2011;16(1):112\u201320.","journal-title":"Oncologist"},{"issue":"20","key":"208_CR38","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1002\/cncr.25396","volume":"116","author":"LW Jones","year":"2010","unstructured":"Jones LW, Watson D, Herndon JE 2nd, Eves ND, Haithcock BE, Loewen G, et al. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer. 2010;116(20):4825\u201332.","journal-title":"Cancer"},{"key":"208_CR39","first-page":"28735","volume":"42","author":"I Fr\u00e9sard","year":"2013","unstructured":"Fr\u00e9sard I, Mass\u00e9 N, Bahtia C, Triponez F, Robert J, Licker M, et al. Reduction of peak oxygen consumption in patients with non-small cell lung cancer treated with neoadjuvant chemotherapy. Eur Respir J. 2013;42:28735. Available from: https:\/\/api.semanticscholar.org\/CorpusID:71044224.","journal-title":"Eur Respir J."},{"key":"208_CR40","unstructured":"Li X, Wang J, Zhang J, Zhang N, Wu C, Geng Z, et al. The effect of exercise on weight and body composition of breast cancer patients undergoing chemotherapy: a systematic review. Cancer Nurs. 9900; Available from: https:\/\/journals.lww.com\/cancernursingonline\/fulltext\/9900\/the_effect_of_exercise_on_weight_and_body.93.aspx"},{"issue":"9","key":"208_CR41","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1177\/2047487314557962","volume":"22","author":"B Krachler","year":"2015","unstructured":"Krachler B, Savonen K, Komulainen P, Hassinen M, Lakka TA, Rauramaa R. Cardiopulmonary fitness is a function of lean mass, not total body weight: the DRs EXTRA study. Eur J Prev Cardiol. 2015;22(9):1171\u20139.","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"208_CR42","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/oby.2009.18","volume":"17","author":"ML Irwin","year":"2009","unstructured":"Irwin ML, Alvarez-Reeves M, Cadmus L, Mierzejewski E, Mayne ST, Yu H, et al. Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity (Silver Spring). 2009;17(8):1534\u201341.","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"208_CR43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","volume":"88","author":"GB Stene","year":"2013","unstructured":"Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM. Effect of physical exercise on muscle mass and strength in cancer patients during treatment\u2013a systematic review. Crit Rev Oncol Hematol. 2013;88(3):573\u201393.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"208_CR44","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/S0735-1097(01)01306-7","volume":"37","author":"M Cicoira","year":"2001","unstructured":"Cicoira M, Zanolla L, Franceschini L, Rossi A, Golia G, Zamboni M, et al. Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2001;37(8):2080\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"208_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mito.2018.02.005","volume":"45","author":"AB Morton","year":"2019","unstructured":"Morton AB, Mor Huertas A, Hinkley JM, Ichinoseki-Sekine N, Christou DD, Smuder AJ. Mitochondrial accumulation of doxorubicin in cardiac and diaphragm muscle following exercise preconditioning. Mitochondrion. 2019;45:52\u201362.","journal-title":"Mitochondrion"},{"issue":"8","key":"208_CR46","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1249\/MSS.0000000000000926","volume":"48","author":"EC Bredahl","year":"2016","unstructured":"Bredahl EC, Pfannenstiel KB, Quinn CJ, Hayward R, Hydock DS. Effects of exercise on doxorubicin-induced skeletal muscle dysfunction. Med Sci Sports Exerc. 2016;48(8):1468\u201373.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"208_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.20463\/pan.2020.0010","volume":"24","author":"I Kwon","year":"2020","unstructured":"Kwon I. Protective effects of endurance exercise on skeletal muscle remodeling against doxorubicin-induced myotoxicity in mice. Phys Act Nutr. 2020;24(2):11\u201321.","journal-title":"Phys Act Nutr"},{"issue":"2","key":"208_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/JTO.0b013e318160f36b","volume":"3","author":"LW Jones","year":"2008","unstructured":"Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, et al. Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2008;3(2):194\u20135. https:\/\/doi.org\/10.1097\/JTO.0b013e318160f36b.","journal-title":"J Thorac Oncol."},{"issue":"12","key":"208_CR49","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1007\/s00520-019-04772-7","volume":"27","author":"IR Kleckner","year":"2019","unstructured":"Kleckner IR, Kamen C, Cole C, Fung C, Heckler CE, Guido JJ, et al. Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial. Support Care Cancer. 2019;27(12):4615\u201325.","journal-title":"Support Care Cancer"},{"issue":"3","key":"208_CR50","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1249\/MSS.0000000000002490","volume":"53","author":"AE Hiensch","year":"2021","unstructured":"Hiensch AE, Mijwel S, Bargiela D, Wengstr\u00f6m Y, May AM, Rundqvist H. Inflammation mediates exercise effects on fatigue in patients with breast cancer. Med Sci Sports Exerc. 2021;53(3):496\u2013504.","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"208_CR51","doi-asserted-by":"publisher","first-page":"E46","DOI":"10.1161\/HYP.0000000000000224","volume":"80","author":"JB Cohen","year":"2023","unstructured":"Cohen JB, Brown NJ, Brown SA, Dent S, Van Dorst DCH, Herrmann SM, et al. Cancer therapy-related hypertension: a scientific statement from the American Heart Association. Hypertension. 2023;80(3):E46-57.","journal-title":"Hypertension"},{"issue":"6","key":"208_CR52","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.clbc.2023.04.010","volume":"23","author":"YL Tsai","year":"2023","unstructured":"Tsai YL, Chuang YC, Chen CP, Lee YC, Cheng YY, Ou-Yang LJ. Feasibility of aerobic exercise training to mitigate cardiotoxicity of breast cancer therapy: a systematic review and meta-analysis. Clin Breast Cancer. 2023;23(6):576\u201390.","journal-title":"Clin Breast Cancer"},{"issue":"17","key":"208_CR53","doi-asserted-by":"publisher","first-page":"e021580","DOI":"10.1161\/JAHA.121.021580","volume":"10","author":"WR Naaktgeboren","year":"2021","unstructured":"Naaktgeboren WR, Binyam D, Stuiver MM, Aaronson NK, Teske AJ, van Harten WH, et al. Efficacy of physical exercise to offset anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of clinical and preclinical studies. J Am Heart Assoc. 2021;10(17):e021580.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"208_CR54","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1038\/s41598-021-83877-8","volume":"11","author":"PV da C Ghignatti","year":"2021","unstructured":"Ghignatti PV da C, Nogueira LJ, Lehnen AM, Leguisamo NM. Cardioprotective effects of exercise training on doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis of preclinical studies. Sci Rep. 2021;11(1):6330.","journal-title":"Sci Rep."},{"issue":"1","key":"208_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40959-019-0054-5","volume":"5","author":"N Bansal","year":"2019","unstructured":"Bansal N, Adams MJ, Ganatra S, Colan SD, Aggarwal S, Steiner R, et al. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors. Cardio-Oncology. 2019;5(1):1\u201322.","journal-title":"Cardio-Oncology"},{"issue":"1","key":"208_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40959-023-00159-0","volume":"9","author":"A Mir","year":"2023","unstructured":"Mir A, Badi Y, Bugazia S, Nourelden AZ, Fathallah AH, Ragab KM, et al. Efficacy and safety of cardioprotective drugs in chemotherapy-induced cardiotoxicity: an updated systematic review & network meta-analysis. Cardio-Oncology [Internet]. 2023;9(1):1\u201334. https:\/\/doi.org\/10.1186\/s40959-023-00159-0.","journal-title":"Cardio-Oncology [Internet]"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-024-00208-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-024-00208-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-024-00208-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T16:09:27Z","timestamp":1708704567000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiooncologyjournal.biomedcentral.com\/articles\/10.1186\/s40959-024-00208-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1186\/s40959-024-00208-2","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}